YTHDF1 Regulates RELA m6A Modification and Activates the NF‐Kappa B Signaling Pathway to Promote the Mechanism of Gastric Cancer

ABSTRACT Background Gastric cancer (GC) is an important cause of death. Molecular targeted therapy and immunotherapy are progressing rapidly. It is very important to explore the pathogenesis pathways of GC and provide strong support for its treatment. However, the mechanism of occurrence and develop...

Full description

Saved in:
Bibliographic Details
Main Authors: Yangyuan Huang, Shihao Liang, Liping Li, Qingyu Zeng, Bin Li
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.70611
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832589799401193472
author Yangyuan Huang
Shihao Liang
Liping Li
Qingyu Zeng
Bin Li
author_facet Yangyuan Huang
Shihao Liang
Liping Li
Qingyu Zeng
Bin Li
author_sort Yangyuan Huang
collection DOAJ
description ABSTRACT Background Gastric cancer (GC) is an important cause of death. Molecular targeted therapy and immunotherapy are progressing rapidly. It is very important to explore the pathogenesis pathways of GC and provide strong support for its treatment. However, the mechanism of occurrence and development of GC is still unclear. Methods Online databases and immunohistochemistry (IHC) of clinical samples were used to analyze the differential expression of YTHDF1 in the GC and nearby tissues, and its effect on survival prognosis. In vitro experimental study of GC, other mechanisms and functional analyses were specifically designed and performed too. Results Online data and clinical samples analysis showed that the expression of YTHDF1 in GC was markedly elevated compared to surrounding tissues. Higher YTHDF1 levels were correlated with worse survival outcomes. Analysis of correlation with clinical parameters showed that the expression level of YTHDF1 exhibited a favorable correlation with lymphatic metastases, as well as with PD‐1 and PD‐L1 levels. In vitro studies of YTHDF1 overexpression have demonstrated its ability to enhance GC cell growth and migration while inhibiting apoptosis. Based on our results, RELA is a downstream target of YTHDF1, and YTHDF1 triggers the NF‐κB signaling pathway by regulating RELA translation. Conclusion In comparison to adjacent tissues, GC exhibits significantly elevated YTHDF1 expression. Increased YTHDF1 expression in the GC is correlated with decreased patient survival. Lymph node metastasis and the expression of PD‐1 and PD‐L1 are positively correlated with YTHDF1 levels. YTHDF1 inhibits apoptosis while promoting the migration and proliferation of GC. Additionally, it stimulates the NF‐κB pathway and controls the translation of RELA.
format Article
id doaj-art-d3f3cd35707842aca0a4cf35d0bfc495
institution Kabale University
issn 2045-7634
language English
publishDate 2025-01-01
publisher Wiley
record_format Article
series Cancer Medicine
spelling doaj-art-d3f3cd35707842aca0a4cf35d0bfc4952025-01-24T08:46:07ZengWileyCancer Medicine2045-76342025-01-01142n/an/a10.1002/cam4.70611YTHDF1 Regulates RELA m6A Modification and Activates the NF‐Kappa B Signaling Pathway to Promote the Mechanism of Gastric CancerYangyuan Huang0Shihao Liang1Liping Li2Qingyu Zeng3Bin Li4Department of Gastroenterology Affiliated Hospital of Guilin Medical University Guilin Guangxi People's Republic of ChinaDepartment of Gastroenterology Affiliated Hospital of Guilin Medical University Guilin Guangxi People's Republic of ChinaDepartment of Gastroenterology Affiliated Hospital of Guilin Medical University Guilin Guangxi People's Republic of ChinaDepartment of Gastroenterology Affiliated Hospital of Guilin Medical University Guilin Guangxi People's Republic of ChinaDepartment of Gastroenterology Affiliated Hospital of Guilin Medical University Guilin Guangxi People's Republic of ChinaABSTRACT Background Gastric cancer (GC) is an important cause of death. Molecular targeted therapy and immunotherapy are progressing rapidly. It is very important to explore the pathogenesis pathways of GC and provide strong support for its treatment. However, the mechanism of occurrence and development of GC is still unclear. Methods Online databases and immunohistochemistry (IHC) of clinical samples were used to analyze the differential expression of YTHDF1 in the GC and nearby tissues, and its effect on survival prognosis. In vitro experimental study of GC, other mechanisms and functional analyses were specifically designed and performed too. Results Online data and clinical samples analysis showed that the expression of YTHDF1 in GC was markedly elevated compared to surrounding tissues. Higher YTHDF1 levels were correlated with worse survival outcomes. Analysis of correlation with clinical parameters showed that the expression level of YTHDF1 exhibited a favorable correlation with lymphatic metastases, as well as with PD‐1 and PD‐L1 levels. In vitro studies of YTHDF1 overexpression have demonstrated its ability to enhance GC cell growth and migration while inhibiting apoptosis. Based on our results, RELA is a downstream target of YTHDF1, and YTHDF1 triggers the NF‐κB signaling pathway by regulating RELA translation. Conclusion In comparison to adjacent tissues, GC exhibits significantly elevated YTHDF1 expression. Increased YTHDF1 expression in the GC is correlated with decreased patient survival. Lymph node metastasis and the expression of PD‐1 and PD‐L1 are positively correlated with YTHDF1 levels. YTHDF1 inhibits apoptosis while promoting the migration and proliferation of GC. Additionally, it stimulates the NF‐κB pathway and controls the translation of RELA.https://doi.org/10.1002/cam4.70611gastric cancerNF‐kappa B signaling pathwayRELAYTHDF1
spellingShingle Yangyuan Huang
Shihao Liang
Liping Li
Qingyu Zeng
Bin Li
YTHDF1 Regulates RELA m6A Modification and Activates the NF‐Kappa B Signaling Pathway to Promote the Mechanism of Gastric Cancer
Cancer Medicine
gastric cancer
NF‐kappa B signaling pathway
RELA
YTHDF1
title YTHDF1 Regulates RELA m6A Modification and Activates the NF‐Kappa B Signaling Pathway to Promote the Mechanism of Gastric Cancer
title_full YTHDF1 Regulates RELA m6A Modification and Activates the NF‐Kappa B Signaling Pathway to Promote the Mechanism of Gastric Cancer
title_fullStr YTHDF1 Regulates RELA m6A Modification and Activates the NF‐Kappa B Signaling Pathway to Promote the Mechanism of Gastric Cancer
title_full_unstemmed YTHDF1 Regulates RELA m6A Modification and Activates the NF‐Kappa B Signaling Pathway to Promote the Mechanism of Gastric Cancer
title_short YTHDF1 Regulates RELA m6A Modification and Activates the NF‐Kappa B Signaling Pathway to Promote the Mechanism of Gastric Cancer
title_sort ythdf1 regulates rela m6a modification and activates the nf kappa b signaling pathway to promote the mechanism of gastric cancer
topic gastric cancer
NF‐kappa B signaling pathway
RELA
YTHDF1
url https://doi.org/10.1002/cam4.70611
work_keys_str_mv AT yangyuanhuang ythdf1regulatesrelam6amodificationandactivatesthenfkappabsignalingpathwaytopromotethemechanismofgastriccancer
AT shihaoliang ythdf1regulatesrelam6amodificationandactivatesthenfkappabsignalingpathwaytopromotethemechanismofgastriccancer
AT lipingli ythdf1regulatesrelam6amodificationandactivatesthenfkappabsignalingpathwaytopromotethemechanismofgastriccancer
AT qingyuzeng ythdf1regulatesrelam6amodificationandactivatesthenfkappabsignalingpathwaytopromotethemechanismofgastriccancer
AT binli ythdf1regulatesrelam6amodificationandactivatesthenfkappabsignalingpathwaytopromotethemechanismofgastriccancer